The global re-emergence of TB and other mycobacterial infections have underscored the need for a thorough investigation of the biology of the causative agent, Mycobacterium tuberculosis, at the molecular level. The peculiar features of the bacterium such as slow growth rate, dormancy, unique cell wall composition and resistance towards phagocytosis by macrophages demands a detailed understanding of different essential molecular processes including transcription in this genus. Sequencing of several mycobacterial genomes provided an impetus for understanding the gene function and regulation of this formidable pathogen. Transcriptional regulation is one of the major mechanisms controlling gene expression. While a number of transcription units, promoters, sigma factors, and gene functions were identified and characterized, key features of transcription process are yet to be understood. The current study aims to understand some of the facets of transcription initiation and elongation in mycobacteria. The thesis is divided into five chapters. Chapter 1 introduces the bacterial transcription process. It starts with the description of the central molecule in transcription -the RNA polymerase (RNAP) and its catalytic mechanism. In the next section, each step of the transcription initiation, elongation and termination has been discussed. The mechanistic details as well as the different cellular factors involved in the regulation of the transcription have been discussed. The final part gives an overview of the transcription machinery of the mycobacteria, describing the promoter specificity and regulation of different sigma factors and other transcription factors known till date in mycobacteria. The scope and the objectives of the thesis are presented at the end of this chapter. In Chapter 2, a method of purification of RNAP from mycobacteria for optimized promoter -polymerase interactions is described. In vitro transcription analysis is important to understand the mechanism of transcription. Various assays for the analysis of initiation, elongation and termination form the basis for better understanding of the process. Purified RNAP with high specific activity is necessary to carry out a variety of these specific reactions. The RNAP purified from Mycobacterium smegmatis from exponential phase showed low σA-promoter specificity in promoter -polymerase interaction studies. This is due to the presence of a large number of sigma factors during exponential phase and under-representation of σA required for house - keeping transcription. In vivo reconstitution of RNAP holoenzyme with σA and its purification procedure which resulted in a holoenzyme with stoichiometric σA content is described in this chapter. The reconstituted holoenzyme showed enhanced promoter -specific binding and transcription activity compared to the enzyme isolated using standard procedure. Chapter 3 is aimed at the comparison of promoter - specific events during transcription initiation in mycobacteria. DNA -protein interactions that occur during transcription initiation play an important role in regulating gene expression. To initiate transcription, RNAP binds to promoters in a sequence -specific fashion. This is followed by a series of steps governed by the equilibrium binding and kinetic rate constants, which in turn determine the overall efficiency of the transcription process. The first detailed kinetic analysis of promoter - RNAP interactions during transcription initiation in the σA-dependent promoters PrrnAPCL1, PrrnB and Pgyr of M. smegmatis are presented in this chapter. The promoters show comparable equilibrium binding affinity but differ significantly in open complex formation, kinetics of isomerization and promoter clearance. Furthermore, the two rrn promoters exhibit varied kinetic properties during transcription initiation and appear to be subjected to different modes of regulation. In addition to the distinct kinetic patterns, each one of the house -keeping promoters studied has its own rate-limiting step in the initiation pathway, indicating the differences in their regulation. Moving the focus of the thesis from transcription initiation to elongation, a transcript cleavage factor of M. tuberculosis has been characterized in Chapter 4. After initiation of transcription, a number of proteins participate during elongation and termination by modifying the properties of the RNAP. Gre proteins are one such class of transcription elongation factors which are conserved across bacteria. They regulate transcription by binding near the secondary channel of RNAP, projecting their N-terminal coiled-coil domain into the active center and stimulating hydrolysis of the newly synthesized RNA by RNAP in the backtracked elongation complexes. Rv1080c is a putative gre factor homolog (MtbGre) present in M. tuberculosis.The protein enhanced the efficiency of promoter clearance by lowering the abortive transcription and also rescued the arrested and paused elongation complexes efficiently in the GC rich mycobacterial template. The Gre factor of M. smegmatis encoded by the gene MSMEG_5263 also showed biochemical properties similar to the M. tuberculosis protein. Although the mycobacterial Gre is similar in domain organization and shared the key residues for catalysis and RNAP interaction with Escherichia coli Gre proteins, it could not complement the E. coli strain deficient in Gre factors. Moreover, MtbGre failed to rescue E. coli RNAP stalled elongation complexes, indicating the importance of specific protein - protein interactions for transcript cleavage. Decrease in the level of MtbGre also reduced the bacterial survival by several fold indicating its essential role in mycobacteria and suggesting that a single Gre copes up with the burden of transcription fidelity of the genome. Chapter 5 describes the studies carried out to identify Gre factor homologs in mycobacteria and deciphering their function during transcription. Gre factors are members of a growing family of proteins which regulate RNAP through secondary channel. Apart from the Gre factor, putative members of this class of proteins are identified in both M. smegmatis and M. tuberculosis.The closest homologue of the canonical Gre factor of M. tuberculosis in its genome is Rv3788. The protein has Gre factor like domain organization and possess the key acidic residues required for transcript cleavage activity and the putative hydrophobic RNAP interacting residues in the C-terminus similar to MtbGre. Despite having these common features, Rv3788 did not stimulate transcript cleavage. In contrast, it turns out to be a transcription inhibitor by preventing the binding of NTPs to the enzyme. The transcription inhibition is not promoter specific, and is mediated by its binding to RNAP through the secondary channel with its N-terminus coiled coil domain. Like M. tuberculosis, the fast growing non-pathogenic mycobacteria M. smegmatis also has an ORF (MSMEG_6292) which is homologous to its canonical Gre factor and it interacts with RNAP in a similar manner. However, this protein did not exert any transcript cleavage or inhibitory activities but could compete with the Gre factor for binding to RNAP. The Gre factor homologs in mycobacteria may be involved in regulation by inhibiting transcription or by blocking the RNAP secondary channel from other RNAP active site modulators.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / The ban on the use of industrial antibiotics as performance-enhancing additives by the European Union has stimulated the studies to replace these additives in animal production with other alternatives additives. Among these studies, are the studies that evaluate the essential oils of aromatic plants that can present similar effects to the conventional additives. The objective of this trial was to evaluate the essential oil of Lippia gracilis as an antimicrobial agent against the bacteria Salmonella sp and Escherichia coli, and as a possible performance enhancer in growing Japanese quail diets. The experiment was conducted in a completely randomized design and the birds distributed within six treatments, seven replicates and twelve birds per plot. The treatments were: increasing levels of essential oil (0.0, 100, 200, 300 and 400mg/kg of feed) and a treatment with bacitracin (BMD). An antibiogram test, performance evaluation and quantitative microbiology of the intestinal contents of the birds were evaluated. The antibiogram and the microbiology were analyzed descriptively. For performance, linear and quadratic regressions were used. In addition, the Dunnett Test was used to evaluate with BMD treatment against the others. It was observed that in the in vitro test (antibiogram), the essential oil was effective in inhibiting the growth of Escherichia coli and Salmonella sp. In initial phase, there was reduction in feed intake and an improvement in feed conversion with an increase in the inclusion of Lippia gracilis essential oil in diets. The treatment containing BMD presented higher feed intake from to 200mg/kg of essential oil and greater weight gain from to 100mg/kg of essential oil. In the period from 2 to 35 days, the relative weight of the proventriculus, gizzard and intestine were increased with the inclusion of the essential oil in the diet compared to the BMD treatment. On the other hand, treatment content BMD presented higher feed intake and worse feed conversion compared to other treatments. Concluded that the increase in the levels of Lippia gracilis essential oil from the plateau up to 200 mg/kg reduced feed intake and weight gain from 2 to 21 days of age. In the period from 2 to 35 days of age, the treatment containing BMD provided an increase in feed intake and an improvement in feed conversion compared to the other treatments. / A proibição do uso de antibióticos industriais como aditivos melhoradores de desempenho pela União Europeia estimulou diversas pesquisas objetivando substituir esses aditivos na produção animal por outros naturais. Dentre essas pesquisas, encontram-se os estudos que avaliam os óleos essenciais de plantas aromáticas que podem apresentar efeitos similares aos aditivos convencionais. Com isso, este trabalho teve como objetivo avaliar o óleo essencial do alecrim como agente antimicrobiano frente às bactérias Salmonella sp e Escherichia coli, e como possível melhorador de desempenho em dietas de codornas japonesas em crescimento. O experimento foi conduzido em delineamento inteiramente casualizado e às aves distribuídas dentro de seis tratamentos, sete repetições e doze aves por parcela. Os tratamentos foram: cinco níveis crescentes de óleo essencial (0,0, 100, 200, 300 e 400mg/kg de ração) e um tratamento com bacitracina (BMD). Foi realizado teste de antibiograma, avaliação de desempenho e microbiologia quantitativa do conteúdo intestinal das aves. O antibiograma e a microbiologia foram analisados descritivamente. Para o desempenho, foram realizadas regressões linear e quadrática. Além disso, realizou-se o Teste de Dunnett a fim de avaliar o tratamento BMD frente aos demais. Observou-se que no teste in vitro (antibiograma), o óleo essencial foi efetivo ao inibir o crescimento de Escherichia coli e Salmonella sp. Na fase inicial, houve redução do consumo de ração e melhora na conversão alimentar com o aumento da inclusão do óleo essencial do alecrim às dietas. O tratamento contendo BMD apresentou maior consumo de ração a partir 200mg/kg de óleo essencial e maior ganho de peso a partir de 100mg/kg de óleo essencial. Já no período de 2 a 35 dias, o peso relativo do proventrículo, moela e do intestino foram aumentados com a inclusão do óleo essencial na ração frente ao tratamento contendo BMD. Já o tratamento contendo BMD apresentou maior consumo de ração e pior conversão alimentar em comparação aos demais tratamentos. Conclui-se que o aumento nos níveis do óleo essencial do alecrim da chapada a partir dos 200 mg/kg reduziu o consumo de ração e o ganho de peso na fase de 2 a 21 dias de idade. Já no período de 2 a 35 dias de idade o tratamento contendo BMD proporcionou aumento do consumo de ração e a melhora na conversão alimentar frente aos demais tratamentos. Conclui-se que o aumento nos níveis do óleo essencial do alecrim (Lippia gracilis Shauer) reduziu o consumo de ração e o ganho de peso na fase de 2 a 21 dias de idade. Já no período de 2 a 35 dias de idade, o melhor nível estimado foi de 196,5mg/kg de inclusão do óleo essencial de alecrim na dieta de codornas japonesas. / São Cristóvão, SE

Transcriptional regulation is the principal mechanism in establishing cell-type specific gene activity by exploring an almost infinite space of different combinations of regulatory elements, transcription factors with high precision. Recent efforts have mapped thousands of candidate regulatory elements, of which a great portion is cell-type specific yet it is still unclear as to what fraction of these elements is functional, what genes these elements regulate, or how they are established in a cell-type specific manner. In this dissertation, I will discuss methods and approaches I developed to better understand the role of regulatory elements and transcription factors in gene expression regulation. First, by comparing the transcriptome and chromatin landscape between mouse and human innate immune cells I showed specific gene expression programs are regulated by highly conserved regulatory elements that contain a set of constrained sequence motifs, which can successfully classify gene-induction in both species. Next, using chromatin interactions I accurately defined functional enhancers and their target genes. This fine mapping dramatically improved the prediction of transcriptional changes. Finally, we built a supervised learning approach to detect the short DNA sequences motifs that regulate the activation of regulatory elements following LPS stimulation. This approach detected several transcription factors to be critical in remodeling the epigenetic landscape both across time and individuals. Overall this thesis addresses several important aspects of cis-regulatory elements in transcriptional regulation and started to derive principles and models of gene-expression regulation that address the fundamental question: “How do cis-regulatory elements drive cell-type-specific transcription?”

No description available.

The adhesion of coatings is of high importance in the coating industry and a more thorough understanding of adhesion behavior is required. In this thesis work, seven parameters affecting adhesion of silane-modified poly(urethane urea) (PUSi) coatings on pretreated steel and aluminum substrates were studied. These parameters include substrate type, dry film thickness (20-30 and 60-70 μm), solid content (40, 60, and 70 wt%), resin ratio between two different types of PUSi (PUSi-A: PUSi-B = 70:30, 50:50, and 30:70 wt ratio), crosslinking density, additive, and curing condition. The different pretreatments of substrates include solvent wiping, sandblasting, phosphating, and galvanizing. A commercial paint product (‘yellow topcoat’) was used as a reference for the study of substrates and additives. Several formulations of clearcoat, prepared from the same PUSi resins as the commercial paint product, were mainly used in every experiment. The obtained coatings were tested for their adhesion properties using cross hatch adhesion test, bending test, and humidity resistance test. The film hardness and thermo-mechanical properties were evaluated with König pendulum hardness test and Dynamic Mechanical Analysis (DMA), respectively. Surface energies of all substrates were analyzed with Contact Angle Measurement (CAM). The PUSi-A and PUSi-B resins used in the coating formulations were characterized with Differential Scanning Calorimetry (DSC), Size-Exclusion Chromatography (SEC), and Fourier Transform Infrared Spectroscopy (FT-IR). The results showed a correlation between poor adhesion properties and the relatively low surface energies of some substrates, namely cold-rolled steel (CRS), industrial ACE aluminum, and standard Q aluminum. The use of silane-functional crosslinking agent and silane adhesion promoters in the coatings has greatly enhanced adhesion. The increase in film hardness via increased crosslinking density also did not hinder the adhesion due to the presence of silane groups in the crosslinker. Additionally, increased time and temperature during curing showed positive effects. However, the variation of resin ratio, solid content, and film thickness did not offer significant adhesion improvement in this study. / Adhesionsegenskaperna hos ytbeläggningar är av stor betydelse i färg- och lackindustrin och en djupare förståelse av vidhäftning är av stor betydelse. I detta uppsatsarbete studerades sju parametrar som påverkar vidhäftning av silanmodifierad poly(uretan-urea) (PUSi)-beläggningar på stål- och aluminiumsubstrat. Dessa parametrar inkluderar substrattyp, torr filmtjocklek (20-30 och 60-70 μm), torrhalt (40, 60 och 70 viktprocent), mängdförhållandet mellan två olika typer av PUSi (PUSi-A: PUSi-B = 70:30, 50:50 och 30:70 viktprocent), tvärbindningsdensitet, tillsatsmedel och härdningsbetingelser. Förbehandlingen av substraten inkluderar lösningsmedelsavtorkning, sandblästring, fosfatering och galvanisering. En kommersiell ytbehandlingsprodukt innehållandes gula pigment (gul topplack) användes som referens. Flera formuleringar av klarlack, framställda av samma PUSi-hartser som den kommersiella produkten, användes i det experimentella arbetet. Beläggningarna testades med avseende på deras vidhäftningsegenskaper med ’cross-hatch’-test, böjningstest och fuktbeständighetstest. Filmhårdhet och termomekaniska egenskaper utvärderades med König pendelhårdhetstest respektive Dynamisk Mekanisk Analys (DMA). Ytenergier för alla substrat analyserades med kontaktvinkelmätning (CAM). PUSi-A- och PUSi-B-hartserna som användes i ytbeläggningarna karaktäriserades med Differential Scanning Calorimetry (DSC), Size-Exclusion Chromatography (SEC) och Fourier Transform Infrared Spectroscopy (FT-IR). Resultaten visade en korrelation mellan dålig vidhäftning och låga ytenergier för vissa underlag, främst kallvalsat stål (CRS), industriellt ACE-aluminium och standard Q-aluminium. Användningen av silan-funktionell tvärbindare och en silan-baserad primer förbättrade vidhäftningen avsevärt. Ökningen i filmhårdhet genom högre tvärbindningsdensitet resulterade inte i sämre vidhäftning eftersom tvärbindaren innehåller silan-grupper vilket bidrog till att upprätthålla vidhäftningen. Längre tid och högre temperatur vid härdning gav generellt bättre vidhäftning, liksom tillsats av urea. Att variera mängden bindemedel, torrhalt eller filmtjocklek gav inte någon signifikant påverkan på vidhäftning i denna studie.

La dystrophie musculaire de Duchenne (DMD) est une maladie très sévère, progressive et sans traitement vraiment efficace. Elle est caractérisée par l’absence fonctionnelle de la dystrophine, une protéine essentielle au maintien des muscles squelettiques. La thérapie génique est actuellement envisagée comme approche thérapeutique pour livrer la dystrophine dans les muscles. Les vecteurs adénoviraux de troisième génération (Helper-dependent adenoviral vector, HD) sont des véhicules de transfert génique très prometteurs pour traiter la DMD. Puisque les gènes adénoviraux ont été enlevés complètement du HD, ils sont peu toxiques, faiblement immunogéniques et ils possèdent un espace cargo suffisant pour transporter l’ADN codant complet de la dystrophine. Bien que le HD puisse fournir la dystrophine de façon thérapeutique chez des souris dystrophiques (mdx), l’expression du gène thérapeutique est progressivement perdue plusieurs mois suivant l’injection intramusculaire. Deux stratégies innovantes furent explorées dans cette thèse dans le but de stabiliser l’expression de la dystrophine. La première stratégie vise à l’intégration de l’ADN du HD dans les chromosomes cellulaires, ce qui pourrait le protéger contre son élimination progressive des muscles. Une intégrase site-spécifique issue du phage ΦC31 a été utilisée pour catalyser l’intégration d’un HD transportant un marqueur de sélection. Dans les cellules humaines et les myoblastes murins, l’activité de l’intégrase a été évaluée d’après son efficacité d’intégration (après sélection) et sa spécificité (dans les clones résistants). L’efficacité atteint jusqu’à 0,5 % par cellule et jusqu’à 76 % des événements d’intégration ont été réalisés de façon site-spécifique. Bien que des délétions aient été trouvées aux extrémités du vecteur, 70 % des clones analysés montraient une seule copie du vecteur intégré (le nombre attendu). Seulement une petite augmentation du nombre de brisures double-brin a été mesurée dans les myoblastes exprimant l’intégrase. En conclusion, l’intégration du HD est relativement efficace, spécifique et sécuritaire. Cette méthode est très prometteuse, car la dystrophine peut être livrée dans le muscle avec l’aide du HD et l’intégration de l’ADN du HD pourrait stabiliser son expression in vivo. La deuxième stratégie implique l’utilisation d’un nouveau promoteur musculospécifique (ΔUSEx3) pour réduire la toxicité induite liée à une expression trop étendue de la dystrophine. Dans cette étude, nous avons investigué l’effet du contexte viral sur l’activité du promoteur. Un HD et un vecteur lentiviral (LV) ont été construits avec le promoteur ΔUSEx3 pour contrôler l’expression d’un gène rapporteur. Les résultats démontrent que ΔUSEx3 confère une expression puissante, musculospécifique et stable (via le LV) in vitro. L’injection intramusculaire du HD a conduit à une expression puissante du transgène. Ces résultats contrastent avec ceux du LV, car après l’injection de ce dernier, l’expression était faible. La livraison du HD dans le muscle, mais aussi dans plusieurs organes démontre la musculospécificité de ΔUSEx3. Par conséquent, le contexte du vecteur et l’environnement musculaire modulent tous les deux l’activité de ΔUSEx3. Bien que ΔUSEx3 soit musculospécifique, d’autres études sont requises pour déterminer si le promoteur peut stabiliser l’expression de la dystrophine in vivo. / Duchenne muscular dystrophy (DMD) is a severe, progressive and orphan disease that is characterized by the absence of the functional muscle protein dystrophin. Gene therapy is currently investigated as a therapeutic approach to deliver dystrophin into muscles. Helper-dependent adenoviral vectors (HD) are promising gene transfer vehicles for gene therapy of DMD. Because HD are devoid of all adenoviral genes, they are weakly toxic, poorly immunogenic and possess sufficient cargo capacity to carry the full-length dystrophin cDNA. Although HD can provide dystrophin therapeutically in dystrophic mice, gene expression decays months after intramuscular injection. Two strategies that both aimed to stabilize dystrophin expression were explored here. The first strategy involved the integration of HD DNA into cellular chromosomes. Stabilizing HD DNA could prevent its elimination from muscles. A site-specific integrase from phage ΦC31 was used to integrate an HD carrying a selection marker in human cells and murine myoblasts. Efficacy of integration (obtained after selection) reached up to 0.5% per cell, and up to 76% of integration events (in clones) were mediated site-specifically. Although some deletions in HD extremities occurred, 70% of clones analyzed showed one integrated copy of HD (as expected). Only a small increase in the number of double-strand breaks was found in myoblasts expressing the integrase. In conclusion, HD integration was relatively efficient, specific and safe. This method could be used to stabilize dystrophin expression in vivo. The second strategy involved using a muscle-specific promoter (ΔUSEx3) to reduce potential toxicity induced by widespread expression of dystrophin. Because ΔUSEx3 would be delivered by HD, we investigated whether or not the viral context could affect ΔUSEx3 activity. We constructed an HD and a lentiviral vector (LV) carrying a reporter gene under its control. Strong, muscle-specific and stable (with LV) expression was obtained in vitro. Intramuscular injection of HD resulted into a powerful transgene expression contrasting with LV, where expression was relatively weak. Delivery of ΔUSEx3 in multiple tissues by HD demonstrated its muscle-specificity. Therefore, both the viral context and the muscular environments modulate ΔUSEx3 activity. Further studies are required to determine whether or not ΔUSEx3 can stabilize dystrophin expression in vivo.

Vetores lentivirais são ferramentas fundamentais para modificação celular. Sua utilização ganhou destaque devido à capacidade desses em integrar ao genoma de células que estão ou não em divisão. Grande parte dos vetores desenvolvidos são derivados do genoma do Vírus da Imunodeficiência Humana (HIV-1), portanto, modificações foram necessárias a fim de evitar a formação de Partículas Competentes em Replicação (RCLs) e garantir uma utilização segura. Com as modificações, foram produzidos os vetores lentivirais de terceira geração utilizados atualmente. Esses vetores podem ser usados para expressão constitutiva de genes, produção de proteínas recombinantes, produção de animais transgênicos e terapia gênica. Com isso, torna-se necessário o desenvolvimento de vetores lentivirais para aplicação em pesquisa básica e ensaios clínicos. Dessa forma, o presente estudo teve por objetivo a construção de vetores de expressão lentivirais aplicáveis à: 1- expressão constitutiva de genes de interesse e 2-vetores com promotores específicos para expressão de proteínas em megacariócitos. Esse trabalho descreve a construção desses vetores, sua importância e discute suas possíveis aplicações. As sequências selecionadas para produção dos vetores foram: os genes Runx1C e VkorC1 e os promotores proPF4 e proITGA2b. Todas as sequências encontram-se clonadas em vetor de clonagem e estoques de bactérias com esses vetores congeladas em glicerol foram confeccionados. Para a confecção dos vetores lentivirais, o gene Runx1C foi subclonado no vetor lentiviral base p1054-CIGWS sob controle do promotor forte CMV, enquanto o promotor proITGA2b foi subclonado no vetor base p1054-FVIII, em substituição ao promotor CMV, de forma a controlar a expressão de FVIII. Os dois vetores produzidos apresentam ainda o gene para proteína verde GFP precedida do sítio de ligação do ribossomo IRES, com expressão controlada pelo mesmo promotor interno do vetor. O trabalho possibilitou, portanto, a produção de dois vetores lentivirais bi-cistrônicos: p1054-Runx1C e pL-proITGA2b-FVIII. A construção p1054-Runx1C ainda não foi sequenciada, mas foi confirmada por restrição enzimática e apresenta potencial para aplicação em estudos de diferenciação hematopoética. Já a construção pL-proITGA2b-FVIII foi sequenciada, porém sem confirmação da região de ligação do proITGA2b ao vetor. Reações de PCR e de restrição enzimática confirmaram a ligação e sequenciamento mostrou 67% de similaridade entre a região sequenciada e o promotor ITGA2b depositado no banco de dados. Análise funcional foi realizada através da transfecção desse vetor em células HEK-293T. As células transfectadas apresentaram expressão positiva para GFP e secreção de FVIII no sobrenadante celular, evidenciando que o promotor proITGA2b clonado no vetor encontra-se ativo. Esse vetor apresenta potencial para aplicação em terapia gênica para hemofilias, pois apresenta expressão do fator de coagulação direcionado a megacariócitos e plaquetas, células que estão diretamente relacionadas ao processo de coagulação, representando grandes veículos para secreção desses fatores. Ainda, os dois vetores lentivirais gerados apresentam segurança e eficiência elevadas, pois são vetores de terceira geração auto-inativantes (SIN) e apresentam elementos regulatórios que melhoram o transporte e integração do DNA ao genoma hospedeiro. / Lentiviral vectors are fundamental tools for cell modification that gained prominence due to their ability to integrate the genome of non-dividing cells. Most of developed lentiviral vectors are derived from the genome of Human Immunodeficiency Virus (HIV-1), so modifications were necessary in order to avoid the formation of Competent Replication Particles (RCLs) and ensure safer operations. The modifications led to development of third generation lentiviral vectors currently used. These vectors can be used for constitutive gene expression, production of recombinant protein, production of transgenic animals and gene therapy. It\'s evident the need to develop lentiviral vectors for application in basic research and clinical trials. Thus this study aimed to construct lentiviral expression vectors applicable to: 1- constitutive expression of genes of interest and 2-vectors with specific promoters for expression of proteins in megakaryocytes and platelets. This paper describes the construction of these vectors, their importance and discuss their possible applications. Sequences were selected for production of the vectors: genes Runx1C and VkorC1 and proPF4 and proITGA2b promoters. All four sequences are cloned into cloning vectors and stocks of bacteria with these vectors frozen in glycerol were prepared. Lentiviral vectors were engineered from subcloning the sequence Runx1C into the basic lentiviral vector p1054- CIGWS under control of the strong CMV promoter, and from subcloning proITGA2b promoter into p1054-FVIII basic vector, replacing the CMV promoter in order to control the expression of FVIII. Both vectors exhibit the green fluorescence protein GFP gene preceded by a ribosome binding site IRES under control of vector\'s internal promoter. Therefore, this work resulted in the production of two bi-cistronic lentiviral vectors: p1054-Runx1C and pLproITGA2b-FVIII. The p1054-Runx1C construction has not yet been sequenced, but it was confirmed by digestion and has potential for use in hematopoietic differentiation studies. Though, pL-proITGA2b-FVIII construct was sequenced, but the technique didn\'t allow to confirm the binding region between proITGA2b and the vector. Although PCR reaction and digestion confirmed the construction. Sequence analysis showed 67% similarity between the sequenced region and ITGA2b promoter deposited in the database. Functional analysis was performed by transfection of this vector in HEK-293T cells. The transfected cells showed positive expression of GFP and FVIII secretion in cell supernatant, indicating that the proITGA2b promoter cloned into the vector is active. This vector has potential usage in gene therapy for hemophilia, since it can be used to express coagulation factors in megakaryocytes and platelets and these cells are directly related to the clotting process, representing great vehicles for secretion of these factors. Even more, the two lentiviral vectors generated have higher safety and efficiency, as they are self-inactivating (SIN) third-generation vectors and have regulatory elements that enhance transport and integration of DNA into the host genome.

In dieser Arbeit wurde die plastidäre Genexpression hinsichtlich zweier Aspekte untersucht: der Cytokinineinfluss auf die plastidäre Transkription und ihrer Komponenten sowie eine in vivo-Charakterisierung von PrpoB-345, des Promotors des rpoB-Operons im Tabak. Cytokinine beeinflussen die Chloroplastenbiogenese und –funktion. Um den Einfluss von Cytokinin auf die plastidäre Genexpression zu untersuchen, wurden run-on-Transkriptionsassays und quantitative real-time RT-PCR von BA-behandelten seneszenten Tabakblättern und sieben-Tage-alten Arabidopsis- und Tabakpflanzen durchgeführt. Zeitreihenanalysen zeigten eine Aktivierung der plastidären Transkription in jungen Pflanzen und im seneszenten Tabak 2 h bzw. 3 h nach BA-Applikation. Abgeschnittene Blätter von Tabakmutanten mit konstitutiv reduziertem Cytokiningehalt antworteten bereits nach 30 min der Hormonbehandlung. Es gibt jedoch keinen eindeutigen Hinweis für eine direkte Korrelation zwischen der Expression der nukleär kodierten Phagentyp-RNA-Polymerasen und der BA-induzierten transkriptionellen Aktivierung der Plastidengene. Zusammengefasst, scheint die Antwort auf exogenes Cytokinin vom physiologischen Status der Chloroplasten, die von der Pflanzenart sowie vom endogenen Cytokiningehalt beeinflusst werden, abzuhängen. Plastidäre Gene höherer Pflanzen werden von mindestens zwei RNA-Polymerasen transkribiert: die plastidär kodierte RNA-Polymerase vom Bakterientyp (PEP) und die kernkodierte Phagentyp-RNA-Polymerase (NEP). NEP transkribiert das rpoB-Operon, das drei von vier Untereinheiten der PEP kodiert. Transkriptions- und Transkriptanalysen von rpoB-Promotor-Deletionsmutanten ergaben Hinweise auf mögliche Regulationsstellen der Kontrolle der rpoB-Transkription. Neben PrpoB-345 konnten zwei weitere Promotoren kartiert werden. Einer von ihnen ist ein putativer PEP-Promotor, der auf autoregulatorische Rückkopplungsmechanismen bei der PEP-Expression hindeutet. / In this study, plastid gene expression was analyzed focusing on two aspects: the effect of cytokinin on plastid gene transcription and its components, and the in vivo characterization of PrpoB-345, the promoter of the rpoB operon in tobacco. Cytokinins are involved in the control of chloroplast biogenesis and function. To study cytokinin effects on plastid gene expression, chloroplast run-on transcription and quantitative real-time RT-PCR from senescent tobacco leaves as well as Arabidopsis and tobacco seedlings after BA treatment were performed. Analyses of time series revealed that BA-induced changes in plastid gene expression are seemingly under circadian and homeostatic control. After 2 h and 3 h of incubation with cytokinin, a stimulation of chloroplast transcription could be observed in seedlings and senescent leaves, respectively. Detached leaves of tobacco mutants with reduced endogenous cytokinin content responded even faster to BA (30 min). There is no indication of direct correlation of the expression of nuclear-encoded plastid phage-type RNA-polymerases and the BA-induced transcriptional activation of plastid genes. In summary, the responsiveness to exogenous cytokinin depends on the physiological status of chloroplasts influenced by plant species and endogenous cytokinin pool. Plastid genes of higher plants are transcribed by at least two RNA polymerases: the plastid-encoded eubacterial-type RNA polymerase (PEP) and the nucleus-encoded phage-type RNA polymerase (NEP). NEP transcribes the rpoB operon encoding three of four subunits of PEP. Transcription and transcript analyses from rpoB promoter deletion mutants indicated putative regulatory sites of control of rpoB transcription which may also interact with (cytokinin-regulated) specificity factors. Beside PrpoB-345, two additional rpoB promoters could be mapped. One of them is a putative PEP promoter which may imply autoregulatory loops of PEP expression.

Em ultimas décadas, a conversão de alcanos leves em suas correspondentes olefinas tem sido objeto de intensas pesquisas, impulsionadas inclusive pelo aumento crescente da demanda do propileno como um importante produto petroquímico. A desidrogenação oxidativa (ODH) do propano representa uma via alternativa promissor para a produção de propeno, ao apresentar-se como uma reação exotérmica e não limitada termodinamicamente. Diferentes óxidos suportados ou mistos têm sido desenvolvidos com a finalidade de aumentar a atividade e seletividade em relação as olefinas. Metais alcalinos são importantes agentes promotores que proporcionam uma melhor seletividade as olefinas devido a redução da acidez e aumento da basicidade da superfície do catalisador. A proposta deste presente trabalho foi desenvolver metodologias de síntese de catalisadores de oxido de vanádio suportado em aluminas de diferentes fases cristalinas e dopados com sódio ou potássio a fim de avalia-los em testes catalíticos de desidrogenação oxidativa do propano. Para tanto, foram utilizadas as seguintes técnicas de caracterização: volumetria N2, difratometria de raios X (DRX) e redução a temperatura programada (RTP). As características acidas e/ou básicas dos suportes e catalisadores foram avaliadas pelas reações de decomposição de isopropanol. / In recent decades, the conversion of light alkanes to their corresponding olefins has been the subject of intense research, mainly driven by the increasing demand of propylene as an important petrochemical product. Oxidative dehydrogenation (ODH) propane is a promising alternative way to propylene production, which it is presented as an exothermic reaction and not limited thermodynamically. Different supported or mixed oxides have been developed in order to increase the activity and selectivity to olefins. Alkali metals are important promoters, which provide improved selectivity to olefins due to reduction of acidity and increasing basicity of the catalyst surface. The purpose of the present study was to develop synthesis methods of vanadium oxide catalysts supported on alumina of the different crystalline phases and doped with sodium or potassium in order to evaluate them in catalytic tests of propane oxidative dehydrogenation. For in such a way, the following characterization techniques were used: N2 volumetry, X-ray diffractometry (XRD) and temperature programmed reduction (TPR). The properties acid and/or basic of supports and catalysts were evaluated by the isopropanol decomposition reaction.

Vetores lentivirais são ferramentas fundamentais para modificação celular. Sua utilização ganhou destaque devido à capacidade desses em integrar ao genoma de células que estão ou não em divisão. Grande parte dos vetores desenvolvidos são derivados do genoma do Vírus da Imunodeficiência Humana (HIV-1), portanto, modificações foram necessárias a fim de evitar a formação de Partículas Competentes em Replicação (RCLs) e garantir uma utilização segura. Com as modificações, foram produzidos os vetores lentivirais de terceira geração utilizados atualmente. Esses vetores podem ser usados para expressão constitutiva de genes, produção de proteínas recombinantes, produção de animais transgênicos e terapia gênica. Com isso, torna-se necessário o desenvolvimento de vetores lentivirais para aplicação em pesquisa básica e ensaios clínicos. Dessa forma, o presente estudo teve por objetivo a construção de vetores de expressão lentivirais aplicáveis à: 1- expressão constitutiva de genes de interesse e 2-vetores com promotores específicos para expressão de proteínas em megacariócitos. Esse trabalho descreve a construção desses vetores, sua importância e discute suas possíveis aplicações. As sequências selecionadas para produção dos vetores foram: os genes Runx1C e VkorC1 e os promotores proPF4 e proITGA2b. Todas as sequências encontram-se clonadas em vetor de clonagem e estoques de bactérias com esses vetores congeladas em glicerol foram confeccionados. Para a confecção dos vetores lentivirais, o gene Runx1C foi subclonado no vetor lentiviral base p1054-CIGWS sob controle do promotor forte CMV, enquanto o promotor proITGA2b foi subclonado no vetor base p1054-FVIII, em substituição ao promotor CMV, de forma a controlar a expressão de FVIII. Os dois vetores produzidos apresentam ainda o gene para proteína verde GFP precedida do sítio de ligação do ribossomo IRES, com expressão controlada pelo mesmo promotor interno do vetor. O trabalho possibilitou, portanto, a produção de dois vetores lentivirais bi-cistrônicos: p1054-Runx1C e pL-proITGA2b-FVIII. A construção p1054-Runx1C ainda não foi sequenciada, mas foi confirmada por restrição enzimática e apresenta potencial para aplicação em estudos de diferenciação hematopoética. Já a construção pL-proITGA2b-FVIII foi sequenciada, porém sem confirmação da região de ligação do proITGA2b ao vetor. Reações de PCR e de restrição enzimática confirmaram a ligação e sequenciamento mostrou 67% de similaridade entre a região sequenciada e o promotor ITGA2b depositado no banco de dados. Análise funcional foi realizada através da transfecção desse vetor em células HEK-293T. As células transfectadas apresentaram expressão positiva para GFP e secreção de FVIII no sobrenadante celular, evidenciando que o promotor proITGA2b clonado no vetor encontra-se ativo. Esse vetor apresenta potencial para aplicação em terapia gênica para hemofilias, pois apresenta expressão do fator de coagulação direcionado a megacariócitos e plaquetas, células que estão diretamente relacionadas ao processo de coagulação, representando grandes veículos para secreção desses fatores. Ainda, os dois vetores lentivirais gerados apresentam segurança e eficiência elevadas, pois são vetores de terceira geração auto-inativantes (SIN) e apresentam elementos regulatórios que melhoram o transporte e integração do DNA ao genoma hospedeiro. / Lentiviral vectors are fundamental tools for cell modification that gained prominence due to their ability to integrate the genome of non-dividing cells. Most of developed lentiviral vectors are derived from the genome of Human Immunodeficiency Virus (HIV-1), so modifications were necessary in order to avoid the formation of Competent Replication Particles (RCLs) and ensure safer operations. The modifications led to development of third generation lentiviral vectors currently used. These vectors can be used for constitutive gene expression, production of recombinant protein, production of transgenic animals and gene therapy. It\'s evident the need to develop lentiviral vectors for application in basic research and clinical trials. Thus this study aimed to construct lentiviral expression vectors applicable to: 1- constitutive expression of genes of interest and 2-vectors with specific promoters for expression of proteins in megakaryocytes and platelets. This paper describes the construction of these vectors, their importance and discuss their possible applications. Sequences were selected for production of the vectors: genes Runx1C and VkorC1 and proPF4 and proITGA2b promoters. All four sequences are cloned into cloning vectors and stocks of bacteria with these vectors frozen in glycerol were prepared. Lentiviral vectors were engineered from subcloning the sequence Runx1C into the basic lentiviral vector p1054- CIGWS under control of the strong CMV promoter, and from subcloning proITGA2b promoter into p1054-FVIII basic vector, replacing the CMV promoter in order to control the expression of FVIII. Both vectors exhibit the green fluorescence protein GFP gene preceded by a ribosome binding site IRES under control of vector\'s internal promoter. Therefore, this work resulted in the production of two bi-cistronic lentiviral vectors: p1054-Runx1C and pLproITGA2b-FVIII. The p1054-Runx1C construction has not yet been sequenced, but it was confirmed by digestion and has potential for use in hematopoietic differentiation studies. Though, pL-proITGA2b-FVIII construct was sequenced, but the technique didn\'t allow to confirm the binding region between proITGA2b and the vector. Although PCR reaction and digestion confirmed the construction. Sequence analysis showed 67% similarity between the sequenced region and ITGA2b promoter deposited in the database. Functional analysis was performed by transfection of this vector in HEK-293T cells. The transfected cells showed positive expression of GFP and FVIII secretion in cell supernatant, indicating that the proITGA2b promoter cloned into the vector is active. This vector has potential usage in gene therapy for hemophilia, since it can be used to express coagulation factors in megakaryocytes and platelets and these cells are directly related to the clotting process, representing great vehicles for secretion of these factors. Even more, the two lentiviral vectors generated have higher safety and efficiency, as they are self-inactivating (SIN) third-generation vectors and have regulatory elements that enhance transport and integration of DNA into the host genome.